;
Convatec
Pioneering
trusted medical solutions
to improve the lives we touch
Forever caring
Convatec is a global medical products and technologies company, focused on solutions for the management of chronic conditions, with leading positions in advanced wound care, ostomy care, continence care and infusion care. With around 10,000 colleagues, we provide our products and services in almost 100 countries, united by a promise to be forever caring. Our solutions provide a range of benefits, from infection prevention and protection of at-risk skin, to improved patient outcomes and reduced care costs.
;
Our categories
Read more
;
Annual General Meeting 2024
Read more
;
Results for the year ended 31 December 2023
Read more
Press releases
View more press releases
21-Oct-24
Corporate
Infusion Care
Convatec collaborates with AbbVie for VYALEV™ therapy for the treatment of advanced Parkinson’s disease in the United States
Convatec’s Neria™ Guard will be used to deliver AbbVie’s VYALEV™ therapy (foscarbidopa and foslevodopa) in the United States, following FDA approval
Read more
10-Oct-24
Corporate
Advanced Wound Care
Convatec update on InnovaMatrix® AC clinical data – second randomised controlled trial authorised
Convatec continues to advance clinical evidence for InnovaMatrix® AC
Read more
20-Sep-24
Corporate
Advanced Wound Care
Convatec update on InnovaMatrix® AC clinical data
InnovaMatrix® AC is a pioneering technology in the treatment of wounds
Read more
01-Aug-24
Continence Care
Convatec me+ Companion™ App offers support for millions of intermittent catheter users
New free app offers users a practical tool to ensure their cathing journey starts smoothly
Read more
30-Jul-24
Corporate
Financial Performance
Interim Results for the six months ended 30 June 2024
Strong broad-based revenue growth and further strategic progress
Read more
26-Jul-24
Continence Care
Convatec’s pioneering catheter for women continues to scale up in Europe
The new compact offering blends gentle, protective cathing with everyday discretion and ease of use.
Read more
16-May-24
Corporate
Financial Performance
AGM trading update for the four months ended 30 April 2024
Revenue continued to build, further strategic progress, on track to deliver financial guidance
Read more
01-May-24
Advanced Wound Care
Convatec unveils significant advanced wound care clinical study results
New research demonstrates superiority of AQUACEL® Ag+ Extra™ dressing in the management of venous leg ulcers
Read more
06-Mar-24
Corporate
Financial Performance
Annual Results for the twelve months ended 31 December 2023
Read more
29-Feb-24
Ostomy Care
Convatec launches new Esteem Body™ with Leak Defense™
Read more
11-Jan-24
Infusion Care
Convatec expands support for people living with advanced Parkinson´s disease
Read more
View more press releases